New York Life Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

New York Life Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-274,472	Closed	-$10.8M	–	1339
2023 Q2	$10.8M	Buy	+274,472	New	+$9.69M	0.11%	165

New York Life Investment Management's ISEE Position: Q3 2023 in Review

New York Life Investment Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 274,472 shares — an estimated $10.8M sold.

New York Life Investment Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $10.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

New York Life Investment Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
New York Life Investment Management sold 274,472 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $10.8M.
New York Life Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
New York Life Investment Management's IVERIC bio, Inc. Common Stock position peaked at $10.8M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on New York Life Investment Management's 13F filing for Q3 2023, filed 8 Nov 2023.